spacer
spacer

PDBsum entry 8api

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Proteinase inhibitor PDB id
8api
Contents
Protein chains
340 a.a. *
36 a.a. *
Ligands
NAG-NAG-MAN-MAN-
NAG-MAN
NAG-NAG ×2
CYS
Waters ×159
* Residue conservation analysis

References listed in PDB file
Key reference
Title The s variant of human alpha 1-Antitrypsin, Structure and implications for function and metabolism.
Authors R.Engh, H.Löbermann, M.Schneider, G.Wiegand, R.Huber, C.B.Laurell.
Ref. Protein Eng, 1989, 2, 407-415.
PubMed id 2785270
Abstract
The S variant of the human alpha 1-antitrypsin with E-264----V, is responsible for a mild alpha 1-antitrypsin deficiency quite common in the European population. S protein specifically cleaved at the susceptible peptide bond was crystallized and its crystal structure determined and refined to 3.1 A resolution. The S variant crystallizes isomorphous to the normal M variant. The difference Fourier electron density map shows the E----V change as outstanding residual density. In addition, small structural changes of the main polypeptide chain radiate from the site of mutation and affect parts far removed from it. By the mutation, internal hydrogen bonds and salt linkages of E-264 to Y-38 and K-487, respectively, are lost. They cause the far-reaching slight distortions and are probably related to the reduced thermal stability of the S mutant. They may also be responsible for slower folding of the polypeptide chain and the clinical symptoms of alpha 1-antitrypsin deficiency. In a theoretical study by molecular dynamics methods simulations of the M and S proteins were made and the results analysed with respect to structural and dynamic properties and compared with the experimental results. There is a significant correlation between experimental and theoretical results in some respects.
Secondary reference #1
Title Human alpha 1-Proteinase inhibitor. Crystal structure analysis of two crystal modifications, Molecular model and preliminary analysis of the implications for function.
Authors H.Loebermann, R.Tokuoka, J.Deisenhofer, R.Huber.
Ref. J Mol Biol, 1984, 177, 531-557. [DOI no: 10.1016/0022-2836(84)90298-5]
PubMed id 6332197
Full text Abstract
Figure 4.
IG. 4. (a) and (b) Stereo diagram of the arrangement of sheets A to C. (Figs 3(b), 3(c), 4(b) and 5 were produced with a program by Lesk & Hardman (1982).)
Figure 6.
FIG. 6. Stereo diagrams of the distribution of (a) apolar, (1)) acidic and (c) basic residues in cc,-proteinase inhibitor.
The above figures are reproduced from the cited reference with permission from Elsevier
Secondary reference #2
Title Interaction of human alpha 1-Proteinase inhibitor with chymotrypsinogen a and crystallization of a proteolytically modified alpha 1-Proteinase inhibitor.
Authors H.Löbermann, F.Lottspeich, W.Bode, R.Huber.
Ref. Hoppe Seylers Z Physiol Chem, 1982, 363, 1377-1388.
PubMed id 6983488
Abstract
Secondary reference #3
Title The biosynthesis of rat alpha 1-Antitrypsin.
Authors J.Carlson, J.Stenflo.
Ref. J Biol Chem, 1982, 257, 12987-12994.
PubMed id 6982267
Abstract
Secondary reference #4
Title Human alpha 1-Antitrypsin: carbohydrate attachment and sequence homology.
Authors R.W.Carrell, J.O.Jeppsson, L.Vaughan, S.O.Brennan, M.C.Owen, D.R.Boswell.
Ref. Febs Lett, 1981, 135, 301-303.
PubMed id 6976274
Abstract
Secondary reference #5
Title Studies on the oligosaccharide chains of human alpha 1-Protease inhibitor. Ii. Structure of oligosaccharides.
Authors T.Mega, E.Lujan, A.Yoshida.
Ref. J Biol Chem, 1980, 255, 4057-4061.
PubMed id 6966283
Abstract
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer